Jan 16 (Reuters) - Paradigm Biopharmaceuticals Ltd:
* ‍GRANTED EUROPEAN PATENT FOR TREATMENT OF BONE MARROW EDEMA LESIONS WITH PENTOSAN POLYSULFATE SODIUM​ Source text for Eikon: Further company coverage:
 